| 4CQE: B-Raf Kinase V600e Mutant In Complex With A Diarylthiazole B Inhibitor reference: Optimization of Diarylthiazole B-Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical Effect., Pulici M, Traquandi G, Marchionni C, Modugno M, Lupi R, Amboldi N, Casale E, Colombo N, Corti L, Fasolini M, Gasparri F, Pastori W, Scolaro A, Donati D, Felder E, Galvani A, Isacchi A, Pesenti E, Ciomei M, ChemMedChem. 2014 Nov 27. doi: 10.1002/cmdc.201402424. PMID: 25430902 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).